Baik Hyun-Man, Su Min-Ying, Yu Hon, Mehta Rita, Nalcioglu Orhan
John Tu and Thomas Center for Functional Onco-Imaging, University of Califorinia, Irvine Hall 164, Irvine, CA 92697-5020, USA.
MAGMA. 2006 May;19(2):96-104. doi: 10.1007/s10334-006-0032-4. Epub 2006 May 9.
The quantification of choline-containing compounds (Cho) in breast tumors by proton MR spectroscopy (1H-MRS) has been of great interest because such compounds have been linked to malignancy. In this study, an internal reference method for the absolute quantification of Cho metabolite in malignant breast tumors was presented using a clinical 1.5 T scanner. We performed in vitro measurements to examine the accuracy of absolute quantification using four phantoms of known choline chloride concentrations. There was a high correlation between the calculated concentrations by MRS and the known concentrations (r2 > 0.98). We applied the technique to in vivo breast study conducted on 45 patients with biopsy-confirmed breast cancer. After T1 and T2 relaxation times were corrected, the Cho levels in this work had a range of 0.76-21.20 mmol/kg from 34 MR spectra of 32 patients with malignant breast lesions. This result was rather consistent with the previously published value (i.e., 1.38-10 mmol/kg, Bolan et al. in Magn Reson Med 50:1134-1143, 2003). Therefore, we conclude that the internal method using the fully relaxed water as a reference could be used for quantifying Cho metabolite accurately in breast cancer patients using a clinical 1.5 T scanner.
通过质子磁共振波谱(1H-MRS)对乳腺肿瘤中含胆碱化合物(Cho)进行定量分析备受关注,因为此类化合物与恶性肿瘤相关。在本研究中,我们使用临床1.5T扫描仪提出了一种用于绝对定量恶性乳腺肿瘤中Cho代谢物的内部参考方法。我们进行了体外测量,使用四种已知氯化胆碱浓度的体模来检验绝对定量的准确性。磁共振波谱计算浓度与已知浓度之间存在高度相关性(r2>0.98)。我们将该技术应用于对45例经活检证实为乳腺癌的患者进行的体内乳腺研究。在对T1和T2弛豫时间进行校正后,从32例患有恶性乳腺病变患者的34个磁共振波谱中得出,本研究中Cho水平范围为0.76 - 21.20 mmol/kg。该结果与先前发表的值(即1.38 - 10 mmol/kg,Bolan等人,《磁共振医学》,2003年,第50卷,第1134 - 1143页)相当一致。因此,我们得出结论,使用完全弛豫水作为参考的内部方法可用于使用临床1.5T扫描仪准确量化乳腺癌患者的Cho代谢物。